There's just one small problem: revenues tend to fall dramatically after a drug loses patent protections. Complicating this ...
For example, Shell's revenues rose 22% in the first half of 2026 compared to the same span in 2025. And its earnings more ...
Companies are using tariff refunds to lower prices, cushion their margins, and, to a very small extent, return the money ...
As founder of the hedge fund company Appaloosa Management, David Tepper has built a reputation for bold, often contrarian ...
Four catalysts hit XRP in rapid succession and sent it from a cycle low to a three-month high, but a wall of sellers is now ...
Ocular Therapeutix recently reported Q2 results that topped revenue and EPS expectations and shared that its pivotal phase 3 ...
Invesco is cutting fees 20% and running a discounted tender offer to clear $2.2B of property fund redemptions in its core ...
Second-quarter earnings across the S&P 500 were robust, with companies tied to artificial intelligence infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results